Histologic study of ovarian endometriosis after hormonal therapy

Nisolle-Pochet M, M Nisolle-Pochet, Michèle Nisolle-Pochet, Casanas-Roux F, F. Casanas-roux, Françoise Casanas‐Roux, J. Donnez, Jacques Donnez, Donnez J
Fertility and sterility · 1988 · vol. 49(3) , pp. 423–426 · doi:10.1016/s0015-0282(16)59766-0 · PMID:3125069 · W1672226597
article OA: closed CC0 ⤵ 96 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

This study examines histological changes in ovarian endometriosis following hormonal therapy, providing insights into treatment-induced tissue alterations.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

To evaluate the persistence of endometriosis and the morphologic changes occurring in endometriotic foci after hormonal therapy, microsurgical resection of ovarian endometriosis was performed in 148 women. After hormonal therapy (n = 116), a high prevalence of active endometriosis without signs of degeneration was found. Mitotic index was similar in the group of untreated women (n = 32) and in the three groups of women treated either with lynestrenol (Organon, Oss, The Netherlands), gestrinone (Roussel UCLAF, Paris, France), or buserelin (Hoechst, Frankfurt, West Germany). In conclusion, hormonal treatment leads to an incomplete suppression of endometriotic foci.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Adult Buserelin Buserelin Endometriosis Endometriosis Female Gestrinone Gestrinone Humans Lynestrenol Lynestrenol

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (18)

Cited by (50)

Source provenance

europepmc
last seen: 2026-08-29T06:12:09.280863+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:09:25.758913+00:00
License: CC0 · commercial use OK